| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $182.5M | — | +0.3% |
| Cost of Revenue | $139.7M | — | +1.7% |
| Gross Profit | $42.8M | — | -3.8% |
| R&D Expense | $24.1M | — | +7.4% |
| SG&A Expense | $23.3M | — | +4.4% |
| Operating Income | -$4.6M | — | -1719.0% |
| Pre-tax Income | -$1.6M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $223.5M | +46.0% | +27.0% |
| Accounts Receivable | $37.1M | +6.7% | +50.9% |
| Inventory | $196.2M | +3.4% | +6.0% |
| Current Assets | $531.3M | +34.1% | +31.9% |
| Total Assets | $1.04B | +0.3% | -8.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.2M | — | -7.6% |
| Capital Expenditures | $9.8M | — | +41.2% |
| Investing Cash Flow | $81.9M | — | +1316.2% |
| Financing Cash Flow | -$21.6M | — | -483.8% |
| Free Cash Flow | $420K | — | -89.8% |
| -252.8% |
| Income Tax | $1.9M | — | +85.3% |
| Net Income | -$2.1M | — | +15.0% |
| EPS (Basic) | -$0.07 | — | +22.2% |
| EPS (Diluted) | -$0.07 | — | +22.2% |
| $161.3M |
| +4.4% |
| +6.3% |
| Long-term Debt | $2.9M | -80.6% | -87.9% |
| Total Liabilities | $203.4M | -4.0% | -16.1% |
| Stockholders' Equity | $834.1M | +1.4% | -6.8% |